Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.
J Immunother Cancer. 2020 Jun;8(1):e000928. doi: 10.1136/jitc-2020-000928.
J Immunother Cancer. 2020.
PMID: 32591433
Free PMC article.
Clinical Trial.
Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.
Ottley EC, Pell R, Brazier B, Hollidge J, Kartsonaki C, Browning L, O'Neill E, Kiltie AE.
Ottley EC, et al. Among authors: hollidge j.
J Pathol Clin Res. 2020 Oct;6(4):238-251. doi: 10.1002/cjp2.167. Epub 2020 May 6.
J Pathol Clin Res. 2020.
PMID: 32374509
Free PMC article.
Item in Clipboard
Cite
Cite